Katarzyna Mitrega

Dr. Katarzyna Mitrega

Silesian Center for Heart Diseases in Zabrze, Poland
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Pharmacological Research
Verified
Journal Article
Closed access
KMKatarzyna Mitrega
Katarzyna Mitrega
MŻMichał Żorniak
Michał Żorniak
BVBenoy Varghese
Benoy Varghese
DLDariusz Lange
Dariusz Lange
JNJerzy Nożynski
Jerzy Nożynski
TKTadeusz F. Krzemiński
Tadeusz F. Krzemiński

Verified
Journal Article
Open access
PDF file
KMKatarzyna Mitrega
Katarzyna Mitrega
Gregory LipGregory Lip
Gregory Lip
BSBeata Sredniawa
Beata Sredniawa
ASAdam Sokal
Adam Sokal
WSWitold Streb
Witold Streb
ZKZbigniew Kalarus
Zbigniew Kalarus
Background: Silent atrial fibrillation (SAF) is common and is associated with poor outcomes. Aims: to study the risk factors for AF and SAF in the elderly (≥65 years) general population and to develop a risk stratification model for predicting SAF. Methods: Continuous ECG monitoring was performed for up to 30 days using a vest-based system in a cohort from NOMED-AF, a cross-sectional study based on a nationwide population sample. The independent risk factors for AF and SAF were determined using multiple logistic regression. ROC analysis was applied to validate the developed risk stratification score. Results: From the total cohort of 3014 subjects, AF was diagnosed in 680 individuals (mean age, 77.5 ± 7.9; 50.1% men) with AF, and, of these, 41% had SAF. Independent associations with an increased risk of AF were age, male gender, coronary heart disease, thyroid diseases, prior ischemic stroke or transient ischemic attack (ICS/TIA), diabetes, heart failure, chronic kidney disease (CKD), obesity, and NT-proBNP >125 ng/mL. The risk factors for SAF were age, male gender, ICS/TIA, diabetes, heart failure, CKD, and NT-proBNP >125 ng/mL. We developed a clinical risk scale (MR-DASH score) that achieved a good level of prediction in the derivation cohort (AUC 0.726) and the validation cohort (AUC 0.730). Conclusions: SAF is associated with various clinical risk factors in a population sample of individuals ≥65 years. Stratifying individuals from the general population according to their risk for SAF may be possible using the MR-DASH score, facilitating targeted screening programs of individuals with a high risk of SAF.

28 February 2023 in Polish Archives of Internal Medicine
Verified
Journal Article
Closed access
KMKatarzyna Mitrega
Katarzyna Mitrega
BSBeata Sredniawa
Beata Sredniawa
ASAdam Y. H. Sokal
Adam Y. H. Sokal
GLGregory Lip
Gregory Lip
KRKrzysztof Rewiuk
Krzysztof Rewiuk
WSWitold Streb
Witold Streb
DOI: 10.20452/pamw.16450, Published online: February 28, 2023, Authors: Katarzyna Mitrega, Beata Sredniawa, Adam Y. H. Sokal, Gregory Lip, Krzysztof Rewiuk, Marcin Rutkowski, Tomasz Zdrojewski, Tomasz Grodzicki, Jaroslaw Kazmierczak, Grzegorz Opolski, Zbigniew Kalarus, Witold Streb

11 July 2016 in Polish Heart Journal
Verified
Journal Article
Closed access
ADAlicja M. Daszyk
Alicja M. Daszyk
KZKatarzyna Zygmund
Katarzyna Zygmund
KMKatarzyna Mitrega
Katarzyna Mitrega
SCSylwia Cebula
Sylwia Cebula
ZKZbigniew Kalarus
Zbigniew Kalarus
BŚBeata Średniawa
Beata Średniawa
Previous studies showed that the presence of fragmented QRS (f-QRS) in patients with acute coronary syndrome (ACS), who underwent complete revascularisation, is associated with worse prognosis and the possibility of arrhythmia occurrence. To assess the prognostic value of f-QRS in patients with ACS and complete revascularisation, in the context of cardiac ar-rhythmias. We analysed 124 consecutive patients (66.1% males; mean age 62.38 ± 11.0 years) with ACS (STEMI 49%) treated invasively. Based on electrocardiogram (ECG) record, performed during the admission to the clinic, after the complete revascularisation (TIMI = 3) and during discharging from hospital (4th-5th days after ACS), we classified QRS as f-QRS based on generally accepted criteria (QRS < 120 ms, which included an additional R wave [R']) or notching in the nadir of the S wave, or > 1 R' (fragmentation) in two contiguous leads, corresponding to a major coronary artery territory. 24-h Holter ECG recording was performed on the fifth day after ACS to assess the frequency of conduction disturbances and others arrhythmias. There were no statistically significant differences between patients with and without f-QRS during hospitalisation. In the patients with f-QRS there were no statistically significant conduction disturbances and other arrhythmias compared to patients without f-QRS at discharge. In the patients with ACS, who underwent successful revascularisation (TIMI = 3), the presence of f-QRS is not correlated with a higher incidence of arrhythmias compared to patients without f-QRS in short-term follow-up.

24 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMonika Kozieł-Siołkowska
Monika Kozieł-Siołkowska
KMKatarzyna Mitrega
Katarzyna Mitrega
TPTomasz Podolecki
Tomasz Podolecki
AOAnna Olma
Anna Olma
ZKZbigniew Kalarus
Zbigniew Kalarus
WSWitold Streb
Witold Streb
Background/Objectives: Increased lipoprotein(a) [Lp(a)] level is associated with elevated possibility of atherosclerosis progression. SYNTAX score enables to grade the anatomy of coronary arteries. To identify the impact of increased Lp(a) level on SYNTAX score in individuals with acute myocardial infarction (AMI). Methods: In our analysis, we enrolled 173 consecutive adult patients hospitalized for AMI in a tertiary cardiology center from December 2022 to August 2023. Patient characteristics were compared for patients with SYNTAX score ≥ 23 (64 patients) and SYNTAX score < 23 (109 patients). The SYNTAX score was estimated based on the results of coronary angiography. Logistic regression analyses were performed to evaluate the factors associated with SYNTAX score. Results: Individuals with the SYNTAX score ≥ 23 were more likely to have arterial hypertension, diabetes mellitus, significant stenosis in the left main coronary artery, and higher Lp(a) levels than those with SYNTAX < 23 (all p < 0.05). On univariate analysis, age (OR 1.05, 95% CI 1.02–1.08, p = 0.001), Lp(a) levels (OR 1.04, 95% CI 1.01–1.06, p = 0.001), and arterial hypertension (OR 2.69, 95% CI 1.26–5.74, p = 0.011) were associated with SYNTAX score ≥ 23. Multivariable determinants of SYNTAX score ≥ 23 were as follows: Lp(a) levels (OR 1.03, 95% CI 1.01–1.08, p = 0.029), and age (OR 1.04, 95% CI 1.01–1.07, p = 0.005). The cut-off value for Lp(a) 166.16 nmol/L identifies patients with SYNTAX score ≥ 23 with 97% sensitivity and 44% specificity (area under curve 0.78, p < 0.001). Conclusions: Elevated Lp(a) concentration is associated with a higher SYNTAX score. A cut-off value of Lp(a) above 166.16 nmol/L allows us to identify subjects with SYNTAX score ≥ 23 with good specificity and sensitivity.

28 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KMKatarzyna Mitrega
Katarzyna Mitrega
MPMaurycy Porc
Maurycy Porc
TKTadeusz F. Krzeminski
Tadeusz F. Krzeminski
We previously established that furnidipine (FUR) and oxy dihydropyridines prevent rats mortality by strong reduction of the lethal arrhythmias in reperfusion. Therefore we decided to study the influence of three main metabolites (M-2, M-3, M-8) of FUR on ischemia-and reperfusion- induced arrhythmias and hemodynamic parameters in rat model to examine their independent activity. The metabolites (M-2, M-3, M-8) were given orally 20 mg/kg (24 and 1 h before ischemia). Mortality was significantly diminished in M-2 and M-3 treated groups with M-3 preventing animal mortality entirely. All three examined substances significantly reduced the duration and incidence of ventricular fibrillation (VF) with M-3, once again, completely preventing VF. Moreover, only M-3 significantly decreased the duration of ventricular tachycardia but had no influence on their incidence. Through the occlusion and reperfusion periods, M-2 and M-3 were markedly less hypotensive than M-8 and did not influence on heart rate. We conclude that two tested metabolites of FUR, M-3 and M-2 exhibited the most pronounced anti-arrhythmic effect being at the same time the most normotensive and therefore caused the most beneficial effects.